Literature DB >> 36250

Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.

G S Stokes, G W Frost, R M Graham, E P MacCarthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 36250     DOI： 10.1002/cpt1979256783

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  Drugs interacting with alpha adrenoceptors.

Authors:  P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 2.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

3.  Alpha blockers and converting enzyme inhibitors.

Authors:  P K Marrott; M Cohen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

4.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

Review 5.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

6.  Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.

Authors:  A J Marshall; M A Kettle; D W Barritt
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

Review 7.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.